ARC Clinical Research, Austin Regional Clinic’s medical research department

that enables clinical trials, is enrolling children 12-17 years old in Pfizer’s COVID-19 vaccine clinical trial that began in early August 2020. 

ARC has enrolled over 200 adult patients since August. Pfizer announced the trial was expanding to younger patients on Oct. 14 and chose a select few research locations to expand to enroll children 12-17. 

ARC is among the research facilities chosen due to ARC’s long track record of conducting high-quality trials and speed in enrolling study participants. The study intends to prove the safety and efficacy of the Pfizer vaccine compound.

“Making sure we study the vaccine among all populations who will need to use it is a top priority,” said Dr. Gretchen Crook, principal investigator for ARC Clinical Research. 

“The virus is not going away anytime soon and developing a vaccine that is safe for all people of all ages is the most promising path to save lives and help us reconnect with our friends and family and return to the activities we all enjoy,”  Cook added.

The study phases for children 12-17 years old are identical to that of the adults, including a vaccine series of two shots and months of follow up. Pfizer is the first COVID-19 vaccine trial to include children, and other research facilities around the country have already started enrolling 12-17 year olds. 

Participants will be compensated for their time and contributions to the clinical study. All COVID-19 vaccine clinical trial services will be delivered at ARC Clinical Research Wilson Parke, located at 11714 Wilson Parke Ave. in Four Points..  

To start the enrollment process for the COVID-19 vaccine study, please go to ARCclinicalresearch.com and click the orange [Request to Participate] button or call 512-225-5931.

In response to COVID-19, ARC has implemented strict safety measures at all clinics and research facilities to ensure that our patients, staff, and physicians remain safe.  Everyone is screened before entering our clinics, sick and well patients wait in separate spaces with symptomatic patients most often waiting in cars, exam rooms are cleaned and disinfected after each visit, and ARC remains fully stocked with personal protective equipment. 

ARC currently participates in seven other research studies at four ARC Clinical Research